Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR8943002

ccb3241d-7064-5953-9e5c-dd189a4cfc6d

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • PANCREAS_BETA_CELLS+0.400
  • KRAS_SIGNALING_DN+0.260
  • KRAS_SIGNALING_UP+0.160
  • SPERMATOGENESIS+0.160
  • HEDGEHOG_SIGNALING+0.130
  • COAGULATION+0.070
  • ALLOGRAFT_REJECTION-0.020
  • MYOGENESIS-0.020
  • APICAL_SURFACE-0.060
  • INFLAMMATORY_RESPONSE-0.070

Top 10 suppressed

  • DNA_REPAIR-0.500
  • MITOTIC_SPINDLE-0.470
  • E2F_TARGETS-0.460
  • G2M_CHECKPOINT-0.460
  • UNFOLDED_PROTEIN_RESPONSE-0.440
  • MYC_TARGETS_V1-0.430
  • MYC_TARGETS_V2-0.430
  • PROTEIN_SECRETION-0.420
  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.420
  • OXIDATIVE_PHOSPHORYLATION-0.380

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

9 twins match this tumor's tissue · 1 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR8942979
bladder-landscape@3
0.957
2TCGA-DK-A1A7-01A-11R-A13Y-07
bladder-landscape@3
0.948
3SRR13311172
bladder-landscape@3
0.948
4TCGA-CF-A3MF-01A-12R-A21D-07
bladder-landscape@3
0.948
5MNG597
mng-umap@100
0.944
6SRR1516040
bladder-landscape@3
0.944
7SRR1394566
brain-umap@2
GTEX0.944
8MNG1133
mng-umap@100
0.943
9MNG1259
mng-umap@100
0.942
10MNG1131
mng-umap@100
0.941

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 6 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
PANCREAS_BETA_CELLS0.400Cobimetinib— uncovered
KRAS_SIGNALING_DN0.260Remibrutinib— uncovered
KRAS_SIGNALING_UP0.160Inavolisib— uncovered
SPERMATOGENESIS0.160Inavolisib— uncovered
HEDGEHOG_SIGNALING0.130Inavolisib— uncovered
COAGULATION0.070Binimetinib— uncovered